Corebridge Financial Brings New Index Strategies and Enhanced Growth Potential to Max Accumulator+ III

Corebridge Financial announced enhancements to its Max Accumulator+ III index universal life insurance product, including new index strategies, as well as changes designed to improve cash value outcomes. These updates are intended to give customers more diversification in how they allocate and build policy value over time and strengthen long-term growth potential.

Read More on Fintech : Global Fintech Interview with Rob Young, Managing Director – UK at InDebted

Corebridge Financial research highlights the financial concerns many Americans report, including healthcare and long-term care costs as well as the possibility of running out of money in retirement.¹ Survey respondents said they would find life insurance living benefits valuable, including financial support during a critical illness (86%), help covering long-term care costs (84%) and a retirement income stream (79%)—closely aligning with their concerns.

Against this backdrop, Corebridge has added two new index interest crediting strategies to Max Accumulator+ III—Nasdaq-100^® providing exposure to technology and growth-oriented companies, and S&P 500^® High Bonus offering a bonus feature designed to support accumulation in varying market conditions.² Max Accumulator+ III now offers five index crediting strategies to achieve greater diversification across market exposures and meet a wider range of customer needs, while maintaining the product’s built-in protections from market loss.³

The latest enhancements to Max Accumulator+ III also support growth potential, helping customers achieve future financial goals with increased cash value over time. Compared to prior product versions, these changes incorporate structural improvements intended to strengthen long-term accumulation.

“Customers are looking for solutions that provide protection today while helping them build more financial flexibility for the future,” said Eric Tarnow, Head of Life Insurance, Corebridge Financial. “With expanded index strategy options and improved cash value potential, Max Accumulator+ III gives customers more choice in how they build policy value over time and helps support the product’s long-term, tax-deferred growth.”

Max Accumulator+ III already features several optional living benefits, including a rider designed to turn a policy’s cash value into a guaranteed lifetime income stream, as well as another that can help cover qualifying chronic illness and care expenses. Some policies may be eligible for Agile Underwriting+, the Corebridge accelerated underwriting process enabling faster decisions without a medical exam, lab work or an attending physician statement.

Policies issued by American General Life Insurance Company (AGL), Houston, TX, except in New York, where issued by The United States Life Insurance Company in the City of New York (US Life). Policy Form Numbers: ICC22-22191, 22191, 23191N, 23191NU; Rider Form Numbers: ICC23-23600, 15600, 13600-5, ICC18-18012, 18012, ICC22-22995, 22995, 14306, 07620, ICC14-14002, 14002, 15996, 15997, ICC15-15994, 15994, ICC18-18004, 18004, ICC23-23602, 15602, ICC23-23603, 15603, ICC23-23604, 15604, 17600N, 18012N, 22995N, 13601N, 07620N, 14002N, 15996N, 18004N, AGLA 04CHIR-CA (0514), AGLA 04CRIR, AGLA 04TIR. AGL does not solicit, issue or deliver policies or contracts in the state of New York. Guarantees are backed by the claims-paying ability of the issuing insurance company, and each company is responsible for the financial obligations of its products. Products may not be available in all states and features may vary by state. Please refer to the policy for more information.

All companies above are wholly owned subsidiaries of Corebridge Financial, Inc. Corebridge Financial and Corebridge are marketing names used by these companies.

This material is general in nature, was developed for educational use only, and is not intended to provide financial, legal, fiduciary, accounting or tax advice, nor is it intended to make any recommendations. Applicable laws and regulations are complex and subject to change. Please consult with your financial professional regarding your situation. For legal, accounting or tax advice consult the appropriate professional.

An Accelerated Death Benefit Rider (ABR) is not a replacement for Long Term Care Insurance (LTCI). It is a life insurance benefit that gives you the option to accelerate some of the death benefit in the event the insured meets the criteria for a qualifying event described in the policy. Some ABRs are conditioned upon the insured not being able to perform two or more of the activities of daily living or being cognitively impaired. The activities of daily living are bathing, continence, dressing, eating, toileting, and transferring. This ABR pays proceeds that are intended to qualify for favorable tax treatment under section 101(g) of the Internal Revenue Code. The federal, state, or local tax consequences resulting from payment of an ABR will depend on the specific facts and circumstances, and consequently advice and guidance should be obtained from a personal tax advisor prior to the receipt of any payments. ABR payments may affect eligibility for, or amounts of, Medicaid or other benefits provided by federal, state, or local government. Death benefits and policy values, such as cash values, premium payments, and cost of insurance charges if applicable, will be reduced if an ABR payment is made. ABR payments may be limited by the contract or by outstanding policy loans.

Nasdaq^®, Nasdaq-100 Index^®, NDX^®, and Nasdaq Stock Market^® are registered trademarks of Nasdaq, Inc. and its affiliates and are licensed for use by American General Life Insurance Company (“AGL”). AGL’s Products (the “Products”) have not been passed on by Nasdaq, Inc. or its affiliates as to their legality or suitability. The Products are not issued, endorsed, sold, or promoted by Nasdaq, Inc. or its affiliates. Nasdaq, Inc. and its affiliates make no warranties and bear no liability with respect to the Products.

Neither Nasdaq, Inc. nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq listed companies or Nasdaq proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence, consult a financial professional and carefully evaluate companies before investing.

The S&P 500^® Index is a product of S&P Dow Jones Indices LLC (‘‘SPDJI’’) and has been licensed for use by AGL and affiliates. Standard & Poor’s^®, S&P^® and S&P 500^® are registered trademarks of Standard & Poor’s Financial Services LLC (‘‘S&P’’); Dow Jones^® is a registered trademark of Dow Jones Trademark Holdings LLC (‘‘Dow Jones’’); and these trademarks have been licensed for use by SPDJI and sublicensed for certain purposes by AGL and affiliates. AGL and affiliates’ products are not sponsored, endorsed, sold, or promoted by SPDJI, Dow Jones, S&P, their respective affiliates, and none of such parties make any representation regarding the advisability of investing in such product(s) nor do they have any liability for any errors, omissions, or interruptions of the S&P 500 Index.

Catch more Fintech Insights : The AI Shift in Fraud: Why Banks Need a New Playbook

[To share your insights with us, please write to [email protected] ]